| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/01/2001 | WO2001013896A1 A vaccine composition and method of using the same |
| 03/01/2001 | WO2001013895A2 Controlled-release sedative-hypnotic compositions and methods related thereto |
| 03/01/2001 | WO2001013893A2 Use of simple amino acids to form porous particles |
| 03/01/2001 | WO2001013892A2 Large porous particles by spray-drying |
| 03/01/2001 | WO2001013891A2 Modulation of release from dry powder formulations |
| 03/01/2001 | WO2001013888A1 Liposome preparations for external use |
| 03/01/2001 | WO2001013887A2 Phospholipin gel |
| 03/01/2001 | WO2001013886A1 Composition for inhalation comprising delta-9-tetrahydrocannabinol in a semiaqueous solvent |
| 03/01/2001 | WO2001013884A2 Cosmetic and/or pharmaceutical preparations with polymers containing polysiloxanes and the uses thereof |
| 03/01/2001 | WO2001013864A1 Water-containing powder composition, process for producing the same, and cosmetic preparation containing the powder composition |
| 03/01/2001 | WO2001013780A2 Apparatus and method for anesthetizing the cervical region of a female |
| 03/01/2001 | WO2001013723A1 Charge reversal of polyion complexes |
| 03/01/2001 | WO2001003670A9 Method for controlled production of ultrafine microparticles and nanoparticles |
| 03/01/2001 | WO2001000181A3 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 03/01/2001 | WO2000078297A3 Stable xylometazoline and oxymetazoline solution |
| 03/01/2001 | WO2000072953A3 A method of producing organic emulsifiers and organic surfactants, products produced by said method, and the use of such products |
| 03/01/2001 | WO2000061190A3 Treatment of intracellular infection |
| 03/01/2001 | WO2000061115A3 Pharmaceutical formulation comprising amoxycillin |
| 03/01/2001 | WO2000059488A3 Enhanced tissue and subcellular delivery of vitamin e compounds |
| 03/01/2001 | WO2000056361A3 Vaccine composition |
| 03/01/2001 | WO2000049038A3 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 03/01/2001 | WO2000048638A3 Multi-mutant diphtheria toxin vaccines |
| 03/01/2001 | WO2000030660A3 Hyperforin as cytostatic agent and hyperforin ointment or cream as application form |
| 03/01/2001 | WO2000023037A8 Two chamber cartridge for atomizers |
| 03/01/2001 | WO1999040214A8 Nucleic acid delivery vehicles |
| 03/01/2001 | WO1998042379A3 Chemically and thermally stable norastemizole formulations |
| 03/01/2001 | WO1998029107A3 Poly(diallylamine)-based bile acid sequestrants |
| 03/01/2001 | DE19940795A1 Schnellzerfallende Pellets auf der Basis von Chitosan Rapidly disintegrating pellets based on chitosan |
| 03/01/2001 | DE19940794A1 Pharmazeutische Zubereitung Pharmaceutical composition |
| 03/01/2001 | DE19940740A1 Pharmazeutische Salze Pharmaceutical Salts |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | CA2383491A1 Large porous particles by spray-drying |
| 03/01/2001 | CA2382867A1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 03/01/2001 | CA2382821A1 Modulation of release from dry powder formulations |
| 03/01/2001 | CA2382820A1 High affinity dna binding compounds as adjuvants in antisense technology |
| 03/01/2001 | CA2382670A1 Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications |
| 03/01/2001 | CA2382652A1 A vaccine composition and method of using the same |
| 03/01/2001 | CA2382220A1 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 03/01/2001 | CA2382217A1 Stable composition for inhalation therapy comprising delta-9-tetrahydrocannabinol and semiaqueous solvent therefor |
| 03/01/2001 | CA2382202A1 Drug conjugates and methods of designing the same |
| 03/01/2001 | CA2382176A1 Recombinant subunit vaccine |
| 03/01/2001 | CA2381571A1 Phospholipid gel |
| 03/01/2001 | CA2381468A1 Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2380730A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | CA2379982A1 Novel compositions for controlled release of a biologically active agent, and the preparation thereof |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376180A1 Oral liquid compositions |
| 02/28/2001 | EP1078638A1 Additive for improving the water resistance of cosmetic or dermatological formulations |
| 02/28/2001 | EP1078636A1 Novel pharmaceutical composition for use in emergency treatment and preparation method thereof |
| 02/28/2001 | EP1078628A2 Multiple unit tableted dosage form |
| 02/28/2001 | EP1078079A1 Methods of forming protein-linked lipidic microparticles, and compositions thereof |
| 02/28/2001 | EP1078003A1 PLASMIN INHIBITORS FROM THE AUSTRALIAN BROWN SNAKE $i(PSEUDONAJA TEXTILIS TEXTILIS) |
| 02/28/2001 | EP1077988A1 Crystal form 0 of clarithromycin |
| 02/28/2001 | EP1077727A1 Adhesive microsphere drug delivery composition |
| 02/28/2001 | EP1077726A2 Inhibiting undesirable taste in oral compositions |
| 02/28/2001 | EP1077721A1 Prevention and treatment of hypergastrinemia |
| 02/28/2001 | EP1077718A1 Enhancement of oxazolidinone antibacterial agents activity by arginine derivatives |
| 02/28/2001 | EP1077713A1 Stable oil-in-glycerin emulsion |
| 02/28/2001 | EP1077707A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 02/28/2001 | EP1077703A1 Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates |
| 02/28/2001 | EP1077692A1 Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same |
| 02/28/2001 | EP1077691A1 Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same |
| 02/28/2001 | EP1077690A1 Use of amyloid inhibitors for modulating neuronal cell death |
| 02/28/2001 | EP1077688A1 Transdermal therapeutic system containing pergolide |
| 02/28/2001 | EP1077687A1 Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 02/28/2001 | EP1077684A1 Effervescent preparations |
| 02/28/2001 | EP1077683A1 Antidepressant therapy |
| 02/28/2001 | EP1077681A1 Pharmaceutical preparation containing levothyroxine sodium |
| 02/28/2001 | EP1077678A1 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 02/28/2001 | EP1077677A1 Biologically active composition |
| 02/28/2001 | EP1077676A2 Cyclosporin preparations |
| 02/28/2001 | EP1077675A1 Therapeutic compositions |
| 02/28/2001 | EP1077669A1 Cosmetic product |
| 02/28/2001 | EP0799027B1 Liposomal interferon hybrid compositions |
| 02/28/2001 | CN1285757A Biodegradable polymer scaffold |
| 02/28/2001 | CN1285753A Transdermal delivery of particulate vaccine compositions |
| 02/28/2001 | CN1285751A Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 02/28/2001 | CN1285749A Penetration enhancing and irritation reducing systems |
| 02/28/2001 | CN1285746A Method and composition of an oral preparation of itraconazole |
| 02/28/2001 | CN1285745A Application of enzyme products as anti-infective agents |
| 02/28/2001 | CN1285744A Use of histamine for elevating blood histamine levels |
| 02/28/2001 | CN1285741A Double capsule for the administration of active principles in multiple therepies |
| 02/28/2001 | CN1285738A Novel oral dosage form for carvedilol |
| 02/28/2001 | CN1285224A Usage of benzoisothiazole ketone compound being used as percutaneous medicine-feeding osmotic promoting agent and preparation process thereof |
| 02/28/2001 | CN1285206A Traditional Chinese medicine fused magnetized xenogenous protein for treating prolapse of lumbar intervertebrai disc and cervical spondylopathy and preparation process thereof |
| 02/28/2001 | CN1285189A Fluoxetine enteric soluble micro-capsule |
| 02/28/2001 | CN1285188A Thermal formed solid releasing-controlled medicinal composition |
| 02/28/2001 | CN1285186A Novel preparation for local use |
| 02/28/2001 | CN1062444C Process for preparation of oral slow-release controlled composition |
| 02/28/2001 | CA2281256A1 Oral compositions having enhanced mouthfeel |
| 02/27/2001 | US6194551 Polypeptide variants |
| 02/27/2001 | US6194543 Dendritic polypeptides |
| 02/27/2001 | US6194468 Including p-menthane-3,8-diol, which has the action of promoting percutaneous absorption, and at least one blood circulation promoter to stimulate hair growth; does not cause side effects |
| 02/27/2001 | US6194462 Pharmaceutical preparation containing nimesulide for oral administration |
| 02/27/2001 | US6194457 Liquid eye drop composition |
| 02/27/2001 | US6194456 Method for inhibiting inflammation |
| 02/27/2001 | US6194430 Viral treatment |
| 02/27/2001 | US6194401 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid |
| 02/27/2001 | US6194395 Liquid injectable and oral solid pharmaceutical dosage forms of a mixture or complex of cladribine and a water solubilizer, a cyclodextrin; storage stability |